Resar
Scoring methodologyReview policyConflicts disclosedNot medical advice
Blueprint Bryan JohnsonAI-curated evidence

Blueprint Bryan Johnson Moisturizer with SFC & NMN – Age-Defying Face Cream for Firmness, Hydration & Barrier Repair – Fragrance Free, Longevity-Inspired Daily Skincare for Smooth, Youthful Skin

Age-Defying Hydration: SFC (Disodium Succinoyl Farnesylcysteine) helps firm, smooth, and visibly reduce fine lines for radiant, youthful-looking skin. * Cellular Renewal: NMN supports skin’s natural repair process to enhance resilience, elasticity, and...

Weak or indirect evidence2 papers indexed · 2 claims mapped

Resar evidence panel

0–100 · cited research only

Evidence Score

35

Limited

Safety Score

80

Strong

Effectiveness Score

50

Emerging

Research Confidence

42

Emerging

Product Fit Score

46

Emerging

Bottom line

Limited evidence (Limited) — treat claims cautiously and review sources directly.

Product fit is weaker — dose, price, or practical use may not align with what studies tested.

Blueprint Bryan Johnson Moisturizer with SFC & NMN – Age-Defying Face Cream for Firmness, Hydration & Barrier Repair – Fragrance Free, Longevity-Inspired Daily Skincare for Smooth, Youthful Skin

Evidence Score

35

Limited

Price

$69.00

Buy on Amazon

Resar may earn an affiliate commission on this purchase. Commissions never change scores — see our affiliate disclosure and conflicts policy. Scores reflect cited research, not medical advice.

Compare others in Skincare

Top research

The strongest studies behind this product

Ranked by evidence hierarchy and how closely each study matches this product. Start with the strongest study, then read down. Every claim needs a trail.

No direct clinical match for this listing

Resar could not find direct human clinical trials supporting this specific formulation. The studies below represent the closest available literature in this category, but do not directly validate the product's claims.

Scores reflect these cited studies, not medical advice. Expand the full evidence detail below for protocols, dose context, and reported side effects.

Claim ledger

Every claim, mapped to its source

Each product claim below is tied to a specific paper with study type, match strength, and limitations. Nothing here is medical advice — it is a research trail you can audit.

Claim match reflects how closely a specific paper supports this benefit — not AI confidence or medical certainty.

Full evidence detail

Study-by-study breakdown

Each paper below is ranked for this listing. Start with the highest match, then expand any study for a plain-language readout.

How to read this section

  • Match % - how closely the study matches this product (not overall scientific quality).
  • Evidence type - study design (RCT, review, etc.) and whether it is direct, category-level, or indirect.
  • What it found - short summary and quoted extract from the paper metadata. Not medical advice.
Weak or indirect evidenceTreat this as background context - the link to this product is weak.

In plain language

48‑week open‑label extension of tapinarof 1% cream in 728 participants (83% pediatric) with atopic dermatitis. 51.9% achieved complete clearance (vIGA‑AD = 0); 81.6% reached clear or almost clear at least once. Median treatment‑free interval after clearance was 79.8 days. Low discontinuation (2.6%). [1]

What the study reported

Verified extract — not AI generated

Clear or almost clear skin in >80% of participants at some point; maintained clearance for ~80 days after stopping treatment.

How it was used

Apply a thin layer of 1% tapinarof cream once daily to affected skin; study allowed up to 48 weeks of continuous use.

Side effects noted

Folliculitis (12.1%), nasopharyngitis (6.9%), upper respiratory infection (6.9%); mild/moderate contact dermatitis; low discontinuation rates.

Caveats

Population had atopic dermatitis, not healthy skin; active ingredient differs from NMN/SFC; open‑label without placebo comparator; results may not translate directly to cosmetic moisturizers.

Read original study

Transparency

Score history

Human review is pending for this listing.

No score changes have been recorded yet.

Reviews

Shopper feedback

N/A

average rating

Amazon review count was not available from the listing metadata.